Should you buy shares of Japara Healthcare Ltd today?

Japara Healthcare Ltd (ASX:JHC) could be a great way to profit from Australia's ageing population.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Japara Healthcare Ltd (ASX: JHC) is an interesting company for investors looking to benefit from Australia's growing and ageing population.

Japara Healthcare is likely to be an unfamiliar name to many investors, given that it only listed its shares on the ASX in April last year. Japara was one of three aged care operators to do so, joining the likes of Estia Health Ltd (ASX: EHE) and Regis Healthcare Ltd (ASX: REG).

Shortly after Japara listed however, its shares experienced a violent drop following a review of its payroll which revealed that it had materially underpaid some employees. It seems that that incident is now a distant memory with the stock now trading at $2.58 which compares to a low of $1.82 in January, and a high of $2.89 in May.

As at 31 December 2014, Japara Healthcare owned and operated 39 aged care facilities with 3,171 operational places spread throughout Victoria, South Australia, New South Wales and Tasmania. Those figures are up 11.4% and 11% year on year, respectively, while it also enjoys 94.4% occupancy rates. Indeed, the company will continue to acquire facilities around Australia with the hope of becoming even better positioned to benefit from Australia's ageing population over the coming years and decades.

According to estimates from Morningstar, the company is set to record earnings per share of 11.2 cents for the 2015 financial year while the company itself expects to pay a full-year dividend of "at least" 10.5 cents per share. That would mean Japara's shares are trading on a multiple of 23x earnings with a yield of 4.1%.

Although Japara Healthcare isn't necessarily 'cheap', nor is it a risk-free investment, it could still be a great prospect for long-term investors.

Motley Fool contributor Ryan Newman has no position in any stocks mentioned. You can follow Ryan on Twitter @ASXvalueinvest. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »